- Home
- ONMD vs MDCX Comparison
ONMD vs MDCX Comparison
Compare ONMD & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- MDCX
- Stock Information
- Founded
- ONMD 2006
- MDCX 2008
- Country
- ONMD United States
- MDCX Canada
- Employees
- ONMD N/A
- MDCX N/A
- Industry
- ONMD
- MDCX
- Sector
- ONMD
- MDCX
- Exchange
- ONMD Nasdaq
- MDCX Nasdaq
- Market Cap
- ONMD 32.5M
- MDCX 33.8M
- IPO Year
- ONMD N/A
- MDCX N/A
- Fundamental
- Price
- ONMD $0.99
- MDCX $4.00
- Analyst Decision
- ONMD
- MDCX Strong Buy
- Analyst Count
- ONMD 0
- MDCX 1
- Target Price
- ONMD N/A
- MDCX $10.00
- AVG Volume (30 Days)
- ONMD 90.9K
- MDCX 42.7K
- Earning Date
- ONMD 12-17-2024
- MDCX 01-01-0001
- Dividend Yield
- ONMD N/A
- MDCX N/A
- EPS Growth
- ONMD N/A
- MDCX N/A
- EPS
- ONMD 0.01
- MDCX N/A
- Revenue
- ONMD $957,651.00
- MDCX N/A
- Revenue This Year
- ONMD N/A
- MDCX N/A
- Revenue Next Year
- ONMD N/A
- MDCX N/A
- P/E Ratio
- ONMD $120.13
- MDCX N/A
- Revenue Growth
- ONMD 1.36
- MDCX N/A
- 52 Week Low
- ONMD $0.46
- MDCX $1.80
- 52 Week High
- ONMD $3.37
- MDCX $4.39
- Technical
- Relative Strength Index (RSI)
- ONMD 45.51
- MDCX N/A
- Support Level
- ONMD $0.90
- MDCX N/A
- Resistance Level
- ONMD $1.06
- MDCX N/A
- Average True Range (ATR)
- ONMD 0.07
- MDCX 0.00
- MACD
- ONMD 0.00
- MDCX 0.00
- Stochastic Oscillator
- ONMD 60.00
- MDCX 0.00
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.